CST1在肝内胆管癌中的表达变化及其对肿瘤细胞恶性生物学行为的影响OA
Expression changes of CST1 in intrahepatic cholangiocarcinoma and its impact on malignant biological behaviors of tumor cells
目的 观察半胱氨酸蛋白酶抑制剂1(CST1)在肝内胆管癌(ICC)组织中的表达变化,并分析其对ICC细胞恶性生物学行为的影响.方法 收集ICC组织、癌旁组织及肿瘤交界组织样本,采用转录组测序分析CST1 mRNA差异表达情况,采用免疫组化法检测CST1蛋白.利用癌症基因组图谱(TCGA)数据库分析CST1基因表达与ICC患者预后的相关性.将ICC细胞分为实验组和对照组,实验组以外源性CST1重组蛋白处理,对照组不给予CST1重组蛋白;采用CCK-8法检测细胞增殖能力,采用划痕愈合实验和Transwell实验检测细胞迁移能力.结果 转录组测序和免疫组化检测结果显示,CST1 mRNA、蛋白在ICC组织中的表达高于癌旁组织和肿瘤交界组织(P均<0.05).基于TCGA数据库的分析显示,CST1基因高表达与ICC患者不良预后相关(P均<0.05).体外实验结果显示,实验组和对照组细胞增殖能力差异无统计学意义(P均>0.05);但实验组划痕愈合实验12、24 h细胞迁移率高于对照组,实验组通过Transwell小室滤膜的细胞数量多于对照组(P均<0.05).结论 CST1在ICC中表达上调,是预后不良的潜在生物标志物,CST1可能通过促进细胞迁移在ICC进展中发挥重要作用.
Objective To observe the expression pattern of Cystatin 1(CST1)in the intrahepatic cholangiocarcinoma(ICC)tissues and to investigate its effects on the malignant biological functions of ICC cells.Methods We collected samples of ICC tissues,adjacent tissues and tumor junction tissues.Transcriptome sequencing was performed to analyze the differential expression of CST1 mRNA.Immunohistochemistry(IHC)was employed to validate the protein expression levels of CST1.Furthermore,the correlation between CST1 mRNA expression and the prognosis of patients with ICC was analyzed using The Cancer Genome Atlas(TCGA)database.ICC cells were divided into the experimental group(treated with exoge-nous recombinant CST1 protein)and control group(without CST1 treatment).The cell proliferation ability was assessed u-sing CCK-8 assay,while the cell migration ability was evaluated using Scratch wound healing and Transwell migration as-says.Results Both transcriptome sequencing and IHC showed that CST1 mRNA and protein expression levels were signifi-cantly higher in ICC tissues than in the adjacent and junction tissues(all P<0.05).Analysis of the TCGA database indica-ted that high CST1 expression was significantly correlated with poor prognosis in ICC patients(P<0.05).In vitro experi-ments demonstrated no statistically significant difference in cell proliferation between the two groups(P>0.05).However,the cell migration rates of the experimental group were higher than those of the control group at 12 and 24 h in the Scratch wound healing assay,and more cells migrated through the Transwell membrane in the experimental group than in the control group(all P<0.05).Conclusion CST1 is up-regulated in ICC and serves as a potential biomarker for poor prognosis,and it may play a crucial role in the progression of ICC by promoting cancer cell migration.
张玉轩;刘孟承;张宫铭;王萌;武凤;段斌炜;孙瑞馨;栗光明;欧阳雅博
首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069首都医科大学附属北京佑安医院普通外科中心 北京肝病研究所,北京 100069
医药卫生
半胱氨酸蛋白酶抑制剂1肝内胆管癌细胞迁移细胞增殖
Cystatin 1intrahepatic cholangiocarcinomacell migrationcell proliferation
《山东医药》 2026 (3)
20-24,5
北京市自然科学基金项目(M21006).
评论